RELATED: Pfizer says COVID-19 vaccine more than 90% effective in kids 5-11The Food and Drug Administration posted its analysis of Pfizer’s data ahead of a public meeting this week to debate whether the shots are ready for the nation’s roughly 28 million children ages 5 to 11.
The agency will ask a panel of outside vaccine experts to vote on that question.The White House COVID-19 Response Team held a briefing on Oct.